格隆汇12月31日丨创元科技(000551.SZ)在互动平台表示，公司控股子公司苏州轴承生产的滚针轴承产 品已应用于汽车领域，其中包括部分无人驾驶相关系统。目前，该类产品在公司整体营业收入中的占比 较小，尚未形成大规模收入贡献。苏州轴承将持续关注无人驾驶等新兴技术的发展趋势，并积极拓展高 端应用场景。 ...

Core Viewpoint - Renben Co., Ltd. has been accepted for an IPO on the Shanghai Stock Exchange, aiming to raise funds for various projects and further solidify its position as a leading bearing manufacturer in China [2] Financial Performance - Total assets increased from 145.89 billion yuan in 2022 to 203.38 billion yuan by June 30, 2025 [3] - Revenue growth from 93.88 billion yuan in 2022 to a projected 119.60 billion yuan in 2024, with a revenue of 64.71 billion yuan for the first half of 2025 [3] - Net profit rose from 6.35 billion yuan in 2022 to an expected 8.29 billion yuan in 2024, with 4.44 billion yuan for the first half of 2025 [3] Profitability Metrics - Basic and diluted earnings per share are projected to be 0.81 yuan for the first half of 2025, up from 1.51 yuan in 2022 [4] - The weighted average return on equity is expected to decrease from 16.03% in 2022 to 5.57% in the first half of 2025 [4] Investment Projects - The IPO aims to raise 3.8 billion yuan for several projects, including: - 600 million yuan for producing 90 million sets of robot and intelligent equipment bearings - 600 million yuan for producing 75 million sets of bearings for new energy vehicles - 700 million yuan for high-reliability precision bearings - 900 million yuan for key component industrialization for high-end equipment - 1 billion yuan for working capital [5] Shareholding Structure - Zhang Tongsheng holds 29.83% of the company's shares directly and controls 60.82% of the voting rights, making him the actual controller of the company [7]

Meeting Overview - The fifth meeting of the board of directors of Changzhou Guangyang Bearing Co., Ltd. was held on December 30, 2025, with all 9 directors present, ensuring the meeting's legality and effectiveness [1]. Board Resolutions - The board unanimously approved the appointment of Mr. Jin Yongsheng as the deputy general manager and committee member, effective until the end of the current board's term [1]. - The board approved a proposal to apply for a working capital loan of RMB 200 million from Huaxia Bank, with a one-year term, to support daily operations [2]. - The board also approved a proposal to apply for a working capital loan of RMB 190 million from China Construction Bank, with a three-year term, secured by credit and deposits [2]. Authorization - The board authorized Chairman Li Shuhua to handle all matters related to the aforementioned credit facilities, including signing contracts and managing funds [3]. Background of New Appointee - Mr. Jin Yongsheng, born in 1981, holds a bachelor's degree in mechanical design and a master's in business administration. He has extensive experience in various managerial roles across different companies [5].

Group 1: Company Overview - Xian New Tong Pharmaceutical Research Co., Ltd. focuses on drug development for major liver diseases, including hepatitis B and liver cancer, with 8 core products in its pipeline [1] - Renben Co., Ltd. is the largest comprehensive bearing manufacturing group in China, with over 50,000 product specifications and a presence in over 70 countries [2] - Wolai Intelligent Technology Co., Ltd. specializes in smart manufacturing solutions for emerging industries, particularly in the automotive and semiconductor sectors [2] - Gaokai Technology is engaged in precision fluid control, with products used in semiconductor and consumer electronics industries [3] - Deep Blue Ocean Technology Co., Ltd. develops underwater robotics and solutions for various marine applications, holding 15 core technologies in the field [3] - Tongxin Medical Technology Co., Ltd. is an innovative medical device company focused on advanced heart failure treatments, with its first product approved in China and others in clinical trials [4] Group 2: Product Development and Market Position - New Tong Pharmaceutical has developed a first-class innovative drug, with one product already on the market and others in various clinical trial stages [1] - Renben has maintained the top position in domestic bearing production and sales for 12 consecutive years, nearing the capabilities of the top eight global competitors [2] - Wolai is recognized as a national key "little giant" enterprise, providing comprehensive smart manufacturing solutions [2] - Gaokai's product range includes flow control and precision dispensing systems, catering to the needs of intelligent manufacturing [3] - Deep Blue has established itself as a pioneer in the underwater robotics sector, with a complete product line and significant R&D investment [3] - Tongxin's CH-VAD system is the first fully magnetic levitation left ventricular assist device approved in China, with further innovations in the pipeline [4]

进一步统计，近3个月内该股累计发生47笔大宗交易，合计成交金额为2.9亿元。该股近5个交易日累计 上涨11.07%，主力资金合计净流入1.86亿元。 12月30日，长盛轴承收涨4.70%，收盘价为88.83元，发生4笔大宗交易，合计成交量69.71万股，成交金 额4790.47万元。 第2笔成交价格为68.72元，成交59.71万股，成交金额4,103.27万元，溢价率为-22.64%，买方营业部为招 商证券股份有限公司成都人民南路证券营业部，卖方营业部为浙商证券股份有限公司嘉善阳光东路证券 营业部。 第3笔成交价格为68.72元，成交3.50万股，成交金额240.52万元，溢价率为-22.64%，买方营业部为浙商 证券股份有限公司青田涌潮街证券营业部，卖方营业部为浙商证券股份有限公司嘉善阳光东路证券营业 部。 第4笔成交价格为68.72元，成交3.50万股，成交金额240.52万元，溢价率为-22.64%，买方营业部为兴业 证券股份有限公司江苏分公司，卖方营业部为浙商证券股份有限公司嘉善阳光东路证券营业部。 第1笔成交价格为68.72元，成交3.00万股，成交金额206.16万元，溢价率为-22.64%，买 ...

每经AI快讯，有投资者在投资者互动平台提问：公司属于宇树机器人的产业链么？ 双飞集团（300817.SZ）12月30日在投资者互动平台表示，截至目前，公司未与宇数机器人开展业务合 作。公司主营业务聚焦无油轴承的研发、生产与销售，核心领域为汽车、工程机械、液压等行业。机器 人产业作为高端装备领域的重要增长点，其对核心零部件的性能要求与公司无油轴承的技术特性存在天 然适配性，公司将持续关注该领域发展动态。公司将始终以市场需求为导向，审慎评估各类新兴业务拓 展机会，相关进展若达到信息披露标准，将及时以公告形式告知。 （文章来源：每日经济新闻） ...

格隆汇12月30日丨双飞集团(300817.SZ)在投资者互动平台表示，截至目前，公司未与宇数机器人开展 业务合作。公司主营业务聚焦无油轴承的研发、生产与销售，核心领域为汽车、工程机械、液压等行 业。机器人产业作为高端装备领域的重要增长点，其对核心零部件的性能要求与公司无油轴承的技术特 性存在天然适配性，公司将持续关注该领域发展动态。公司将始终以市场需求为导向，审慎评估各类新 兴业务拓展机会，相关进展若达到信息披露标准，将及时以公告形式告知。 ...

Core Viewpoint - Renben Co., Ltd. has reinitiated its IPO application on the Shanghai Stock Exchange after a previous unsuccessful attempt, with its application accepted on December 29 [1] Group 1: Business Overview - Renben Co., Ltd. specializes in the research, production, and sales of bearings and related products, possessing a full industry chain capability from materials to finished products [1] - The company offers over 50,000 types of bearing products, which are widely used in automotive, light machinery, heavy machinery, and major equipment sectors [1] Group 2: Revenue Composition - From 2022 to 2025, the revenue from finished bearings consistently accounts for over 86% of total income, with automotive bearings contributing 39.16%, 45%, 45.97%, and 45.07% respectively [1] - Revenue from light machinery bearings represents 28.94%, 25.62%, 24.41%, and 24.59% over the same period [1] Group 3: Major Clients - Key clients in the automotive sector include Geely Group, BYD, Changan Automobile, Great Wall Motors, and Bertley, with Geely being the largest customer [1] Group 4: Financial Performance - The company's revenue for 2022 to 2025 is projected at 9.388 billion, 10.482 billion, 11.96 billion, and 6.471 billion respectively, while net profit is expected to be 585 million, 625 million, 700 million, and 313 million [2] - In 2022, revenue grew by 2.93% year-on-year, but net profit decreased by 20.91% [2] - The gross profit margin slightly declined from 28.64% in 2022 to 26.54% in the first half of 2025 [2] Group 5: Debt and Liquidity - The company has a high asset-liability ratio of 66.63% as of mid-2025, with bank loans constituting 62.39% of total liabilities [2] - The liquidity ratios are below industry averages, with a current ratio of 1.08 compared to the industry average of 2.07, and a quick ratio of 0.76 against an average of 1.63 [2] Group 6: IPO Fundraising and Projects - The company aims to raise 3.8 billion through the IPO, an increase of approximately 40% from the previous target of 2.702 billion [4] - The funds will be allocated to various projects, including the production of 9 million sets of robot and intelligent equipment bearings, 7.5 million sets of new energy vehicle bearings, and other key projects [4]

Core Viewpoint - Renben Co., Ltd. has received approval for its IPO on the Shanghai Stock Exchange, despite facing challenges such as high accounts receivable and a rising debt-to-asset ratio, which reached 67% [1][9]. Financial Performance - The company reported revenues of 93.88 billion, 104.82 billion, 119.60 billion, and 64.71 billion for the years 2022, 2023, 2024, and the first half of 2025, respectively [4]. - Net profits for the same periods were 5.85 billion, 6.25 billion, 7 billion, and 3.13 billion [4]. - As of June 30, 2025, total assets amounted to 203.38 billion, with a debt-to-asset ratio of 66.63% [5][10]. Accounts Receivable - Accounts receivable exceeded 32 billion, representing 28.43% of current assets as of June 30, 2025 [8]. - The company acknowledged potential risks related to the collection of accounts receivable due to market competition and economic conditions [8]. Business Segments - Automotive bearings contributed 45% to the company's revenue in the first half of 2025, highlighting its significance to overall business performance [6][7]. - The company has a diverse product range with over 50,000 types of bearings, serving various sectors including automotive, light and heavy machinery, and major equipment [2]. Debt and Liquidity - The company has a high debt level, with bank loans constituting 62.39% of total liabilities [10]. - Liquidity ratios, including the current ratio of 1.08 and quick ratio of 0.76, are below industry averages of 2.07 and 1.63, respectively [10][11]. IPO and Fundraising - The company plans to raise 3.8 billion through its IPO, with 1 billion allocated for working capital and the remainder for various projects, including the production of bearings for robots and new energy vehicles [12][13]. Regulatory Issues - Some subsidiaries have faced administrative penalties related to tax, environmental, and safety violations, indicating potential operational risks [14][15].

Group 1 - The core viewpoint of the news is that Changsheng Bearing's stock has increased by 1%, reaching a price of 85.69 yuan per share, with a trading volume of 311 million yuan and a turnover rate of 1.89%, resulting in a total market capitalization of 25.602 billion yuan [1] - Changsheng Bearing, established on June 14, 1995, and listed on November 6, 2017, specializes in the research, production, and sales of self-lubricating bearings and high-performance polymers [1] - The revenue composition of Changsheng Bearing's main business includes: 48.26% from metal-plastic polymer self-lubricating rolled bearings, 25.44% from bimetal boundary lubricated rolled bearings, 23.51% from metal-based self-lubricating bearings, and 2.79% from other supplementary products [1] Group 2 - Among the top ten circulating shareholders of Changsheng Bearing, a fund under Southern Fund holds a position, specifically the Southern CSI 1000 ETF (512100), which reduced its holdings by 9,600 shares in the third quarter, now holding 1.0922 million shares, accounting for 0.56% of circulating shares [2] - The Southern CSI 1000 ETF (512100) has a current scale of 76.63 billion yuan and has achieved a return of 29.2% this year, ranking 1850 out of 4195 in its category; over the past year, it has returned 24.73%, ranking 2053 out of 4179 [2]